41
https://pubmed.ncbi.nlm.nih.gov/38116786
Self-assembled nanobiomaterials show potential as safer and more functional alternatives to current nondegradable nanomaterials for activating systemic immune response and converting immunosuppressive tumors to antitumor immune cell-rich microenvironments, but face challenges in clinical translation.